Search Login Register

Peroxisome Proliferator-Activated Receptors (PPAR) Summary

Description: TRANSCRIPTION FACTORS that are activated by ligands and heterodimerize with RETINOID X RECEPTORS and bind to peroxisome proliferator response elements in the promoter regions of target genes.

Also Known As: PPAR; NUC1 PPAR; PPAR, NUC1; Peroxisome Proliferator Activated Receptors; Proliferator-Activated Receptors, Peroxisome Show All >>

Networked: 2013 relevant articles (125 outcomes, 313 trials/studies) for this Bio-Agent

Key Diseases for which Peroxisome Proliferator-Activated Receptors is Relevant

  1. Inflammation : 13 outcomes 34 studies in 426 results
  2. Insulin Resistance : 11 outcomes 13 studies in 165 results
  3. Fibrosis (Cirrhosis) : 11 outcomes 8 studies in 61 results
  4. Obesity : 7 outcomes 25 studies in 161 results
  5. Dyslipidemias (Dyslipidemia) : 7 outcomes 5 studies in 78 results
Show All >>

Drugs Related to Peroxisome Proliferator-Activated Receptors

  1. Ligands
  2. PPAR alpha
  3. pioglitazone (Actos)
  4. Insulin (Novolin)
  5. Fibric Acids (Fibrates)
  6. Peroxisome Proliferator-Activated Receptors (PPAR)
  7. PPAR gamma
  8. Fenofibrate (CiL)
  9. Glucose (Dextrose)
  10. telmisartan (Micardis)
Show All >>

Therapies Related to Peroxisome Proliferator-Activated Receptors

  1. Drug Therapy (Chemotherapy)
  2. Therapeutics
  3. Laminectomy
  4. Ligation
  5. Caloric Restriction
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.